Skip to main content

Influence of Treatment Caused Impairments on Anxiety and Depression in Patients with Cancer of the Esophagus or the Esophagogastric Junction

Journal of Gastrointestinal Cancer volume 51, pages 30–34 (2020)Cite this article

Abstract

Purpose

After therapy of cancer of the esophagus or the esophagogastric junction, patients often suffer from anxiety and depression. Some risk factors for elevated anxiety and depression are reported, but the influence of steatorrhea, the frequency of which has only recently been reported, has not yet been investigated.

Method

Using the Hospital Anxiety and Depression Scale (HADS), we analyzed the correlation of anxiety and depression with steatorrhea, appetite, and weight loss in 72 patients with cancer of the esophagus or of the esophagogastric junction, who were treated at our rehabilitation clinic between January 2011 and December 2014. In addition, effectiveness of psychological interviews was analyzed.

Results

We have evaluable anxiety questionnaires from 51 patients showing a median anxiety value of 5 (range 0–13). As for the depression, results from evaluable questionnaires of 54 patients also showed a median value of 5 (range 0–15). Increased anxiety and depression values (> 7) were observed in 25.4% and 37.0% of the patients respectively. Patients who were admitted with steatorrhea for rehabilitation showed a statistically higher anxiety value (median 6.3 vs. 4.7, p < 0.05), reduced appetite, and a weight loss above 15 kg depicting a correlation to anxiety and depression. Psychological conversations helped lowering the depression but had no influence on anxiety.

Conclusions

Impairments after cancer treatment, such as steatorrhea, appetite loss, and weight loss, should be interpreted as an alarm signal and should necessitate screening for increased anxiety and depression. Psychological therapy can help improving the extent of the depression.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Wolf MC, Zehentmayr F, Schmidt M, Holzel D, Belka C. Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. Radiat Oncol. 2012;7:60–5.

    Article  Google Scholar 

  2. Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6:864–70.

    Article  Google Scholar 

  3. Rutegard M, Charonis K, Lu Y, Lagergren P, Lagergren J, Rouvelas I. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery. 2012;152:903–10.

    Article  Google Scholar 

  4. Derogar M, Orsini N, Sadr-Azodi O, Lagergren P. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012;30:1615–9.

    Article  Google Scholar 

  5. Dempster M, McCorry NK, Brennan E, Donnelly M, Murray L, Johnston BT. Psychological distress among survivors of esophageal cancer: the role of illness cognitions and coping. Dis Esophagus. 2012;25:222–7.

    Article  Google Scholar 

  6. Hellstadius Y, Lagergren P, Lagergren J, Johar A, Hultman CM, Wikman A. Aspects of emotional functioning following oesophageal cancer surgery in a population-based cohort study. Psychooncology. 2015;24:47–53.

    Article  Google Scholar 

  7. McCorry NK, Dempster M, Clarke C, Doyle R. Adjusting to life after esophagectomy: the experience of survivors and carers. Qual Health Res. 2009;19:1485–94.

    Article  Google Scholar 

  8. Bergquist H, Ruth M, Hammerlid E. Psychiatric morbidity among patients with cancer of the esophagus or the gastro-esophageal junction: a prospective, longitudinal evaluation. Dis Esophagus. 2007;20:523–9.

    Article  CAS  Google Scholar 

  9. Dunn LB, Aouizerat BE, Cooper BA, Dodd M, Lee K, West C, et al. Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. Eur J Oncol Nurs. 2012;16:1–9.

    Article  Google Scholar 

  10. Hulbert-Williams N, Neal R, Morrison V, Hood K, Wilkinson C. Anxiety, depression and quality of life after cancer diagnosis: what psychosocial variables best predict how patients adjust? Psychooncology. 2012;21:857–67.

    Article  Google Scholar 

  11. Carlson LE, Waller A, Groff SL, Giese-Davis J, Bultz BD. What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology. 2013;22:168–76.

    Article  Google Scholar 

  12. Lloyd-Williams M, Friedman T. Depression in palliative care patients--a prospective study. Eur J Cancer Care (Engl). 2001;10:270–4.

    Article  CAS  Google Scholar 

  13. Parker PA, Baile WF, de MC, Cohen L. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology. 2013;12:183–93.

    Article  Google Scholar 

  14. Hellstadius Y, Lagergren J, Zylstra J, Gossage J, Davies A, Hultman CM, et al. A longitudinal assessment of psychological distress after oesophageal cancer surgery. Acta Oncol. 2017;56:746–52.

    Article  Google Scholar 

  15. Huddy JR, Macharg FM, Lawn AM, Preston SR. Exocrine pancreatic insufficiency following esophagectomy. Dis Esophagus. 2013;26:594–7.

    Article  CAS  Google Scholar 

  16. Kiefer T, Krahl D, Osthoff K, Thuss-Patience P, Bunse J, Adam U, et al. Importance of pancreatic enzyme replacement therapy after surgery of cancer of the esophagus or the esophagogastric junction. Nutr Cancer. 2017;1–4.

  17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    Article  CAS  Google Scholar 

  18. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.

    Article  Google Scholar 

  19. Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord. 2010;126:335–48.

    Article  Google Scholar 

  20. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik am See, Seebad 84, 15562, Rüdersdorf bei, Berlin, Germany

    Thomas Kiefer, Dorothea Krahl, Heinz Völler & Lorenz Völkel

  2. Department of Internal Medicine C, Hematology/Oncology, University of Greifswald, Greifswald, Germany

    Carsten Hirt

  3. Center of Rehabilitation Research, University of Potsdam, Potsdam, Germany

    Heinz Völler

  4. Department of Dermatology, University Medicine Greifswald, Greifswald, Germany

    Georg Daeschlein

Authors
  1. Thomas Kiefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothea Krahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carsten Hirt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heinz Völler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lorenz Völkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georg Daeschlein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Kiefer.

Ethics declarations

Conflict of Interest

The authors declare that there is no conflict of interest.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent of the patients for being included in the study is not necessary since we present data of retrospectively analyzed data. No informed written consent was obtained.

This article does not contain any studies with animals performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kiefer, T., Krahl, D., Hirt, C. et al. Influence of Treatment Caused Impairments on Anxiety and Depression in Patients with Cancer of the Esophagus or the Esophagogastric Junction. J Gastrointest Canc 51, 30–34 (2020). https://doi.org/10.1007/s12029-018-00193-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-018-00193-7

Keywords

  • Anxiety
  • Depression
  • Esophagus carcinoma
  • Exocrine pancreas insufficiency
  • Rehabilitation
  • Steatorrhea